An excerpt from LCGC's e-learning tutorial on solid-phase extraction at CHROMacademy.com
An excerpt from LCGC's e-learning tutorial on solid-phase extraction at CHROMacademy.com
Solid-phase extraction (SPE) is a sample cleanup and preconcentration technique used to reduce sample and chromatographic complexity or increase analytical sensitivity.
Often called "digital chromatography," the technique uses silica or polymeric stationary phase particles that are often functionalized with various ligands to offer a particular selectivity to compounds partitioning between the liquid mobile phase and solid stationary phase surface. There are many different sorbent chemistries available, including most of the popular high performance liquid chromatography (HPLC) phases, ion exchangers (both weak and strong) and "mixed-mode" phases using both hydrophobic and ionic ligands. Polymers are used as mixed-mode phases and have found widespread use as "generic" phases in which a fixed protocol of solvents can be used across a wide variety of application types.
The sorbent materials are often packed into syringe barrel tubes or well-plate devices and protocol solvents are passed through the packed beds using gravity, vacuum or positive pressure of an inert gas. The amount of sorbent is chosen to reflect the capacity required to retain the analytes of interest, although usually in SPE the mass of all sample components is considered in this calculation and not just the analyte of interest. Silica phases typically have a capacity of around 5% (w/w) by bed mass and polymers around 20% (w/w).
The majority of SPE methods — or protocols as they are often called — have six discrete stages. Sample pretreatment typically involves changing a liquid sample pH, dissolving a solid sample in a suitable solvent or altering the sample buffer strength to ensure maximum retention by the chosen sorbent. Conditioning uses a solvent (often methanol) to activate the bonded phase on the sorbent surface and acts to avoid dewetting effects.
Equilibration prepares the sorbent surface to accept the sample, ensures optimum analyte recovery and minimizes "breakthrough" — this might include adjusting the pH of the solvent within the sorbent bed, altering the ionic strength or changing the type of buffer used. The adjustment of the solvent pH may also be used to control the degree of ionization for ligands containing ionogenic functional groups.
Figure 1: Steps in solid-phase extraction.
Sample loading is usually performed in a similar solvent to that used during the equilibration step, and careful control of solvent flow rate is important to ensure optimum analyte retention, especially where ionic (point to point) interactions are concerned. Flows rates of 1 mL/min are typical.
Washing steps require careful design of the protocol solvent and the eluotropic strength, ionic strength and pH may all be adjusted to ensure that the maximum amount of potentially interfering species are removed while leaving the analyte in as tight a band as possible on the sorbent surface. The specificity of the protocol can be optimized, if required, by using ligands that undergo ion-exchange interactions where the options for chemically differentiating between analyte and interferents include pH, ionic strength and the nature of the counterion used, thus creating cleaner final extracts. More than one washing step may be used if necessary. Method developers commonly use wash solvents that are eluotropically weaker than necessary for fear of analyte loss.
Elution protocol solvents are designed to recover the maximum amount of analyte from the stationary phase while leaving any remaining potential interferents behind, and, once again, percentage of organic modifier, pH, ionic strength and the nature of the counterion are available to maximize analyte recovery. Depending upon the nature of the wash and elution solvents and the mode of analyte retention, a soak step may be used in which the elution solvent is allowed to remain stationary for a fixed period of time, ensuring good penetration into the pores of the stationary phase, minimizing dewetting phenomena and allowing time for the analyte to equilibrate into the elution solvent. Again, a common mistake at this stage is the use of protocol solvents that are "too strong" and elute interfering compounds that could otherwise be left on the sorbent for fear of low analyte recovery. Both wash and elution stages should be carefully optimized to maximize selectivity of the process.
The volume of elution solvent can be altered by changing eluotropic strength to achieve a concentration effect in which the analyte concentration increases with the ratio of sample volume to elution volume. If required, the elution solvent may be evaporated under an inert gas and reconstituted in a solvent more suited to the analytical technique or in a lower volume, again achieving an increase in analyte concentration. This evaporation or reconstitution step provides extra complexity and a possible reduction in precision and should be carefully considered.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
6PPD-Quinone Reference Materials
November 19th 2024Ensure environmental and consumer health with our standards for 6PPD-quinone testing. 6PPD-quinone has been detected in the environment and has shown toxicity to aquatic life. Chiron, by Zeptometrix® offers reference standards suitable for Draft EPA Method 1634.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Microplastics Reference Materials
November 19th 2024The World’s First Microplastics Reference Materials. Our scientists have focused on these emerging global threats, and are excited to share Chiron MicroPrefs®, the first commercial microplastic reference material. The MicroPref® portfolio is designed to detect the six most abundant plastics in the environment and is available in a novel, easy-to-use tablet formulation. Be among the first labs to join in the fight against microplastic pollution by exploring the NEW line of Chiron MicroPrefs® microplastic standards.
RAFA 2024 Highlights: Cutting-Edge Chromatography Techniques for Food Safety and Food Analysis
November 18th 2024An illuminating session focusing on progress in analytical techniques used in food analysis took place on Wednesday 6 November 2024 at RAFA 2024 in Prague, The Czech Republic, including a talk on the analysis of 1000 toxins in 10 minutes.